Sacral Neuromodulation in Patients With Double Incontinence (NCT07212387) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Sacral Neuromodulation in Patients With Double Incontinence
Czechia30 participantsStarted 2025-11
Plain-language summary
This is a prospective study evaluating the effect of a treatment method of sacral neuromodulation (SNM), the use of which is approved and recommended for the treatment of both faecal incontinence (FI) and urinary incontinence (UI). A new aspect of the study is monitoring the effect of SNM in patients with both types of incontinence (faecal and urinary) occurring simultaneously. The study will use diagnostic methods and procedures that are part of the usual examination algorithm. The study will not impose any burden on patients beyond the scope of routine examination and treatment procedures.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult women over 18 years of age
* Consent to participate in the study
* Willingness to undergo examination, treatment and follow-up according to the protocol
* DI symptoms characterized by:
* Grade III fecal incontinence (patient is unable to consciously hold in wind, loose or hard stools)
* At least 2 episodes of fecal incontinence during the week (according to bladder and bowel diary)
* At least 1 episode of involuntary urine leakage per day (according to bladder and bowel diary)
* Total score of the ICIQ-UI SF questionnaire
* DI symptoms for more than 6 months
* Failure of previous conservative treatment
Exclusion Criteria:
* Rapidly progressing neurological diseases
* Known severe congenital malformations of the anorectum and/or lower urinary tract
* Presence of a foreign body in the urinary tract - urolithiasis, urinary catheter, ureteral stent
* Pregnancy, lactation
* Active urinary tract infection
* Active malignant disease
* Clinically significant pelvic organ prolapse
* Active inflammatory bowel disease (Crohn's disease, ulcerative colitis)
* In the case of an associated lesion of the external anal sphincter, a defect greater than 90 degrees
* Previous pelvic radiotherapy less than 12 months prior to study enrolment
* Previous pelvic organ descent surgery less than 12 months prior to study enrolment
* Previous stress urinary incontinence surgery less than 12 months prior to study enrolment
* Previous childbirth less than 12 months prior to s…